Literature DB >> 10776906

Exercise intensity during competition time trials in professional road cycling.

S Padilla1, I Mujika, J Orbañanos, F Angulo.   

Abstract

PURPOSE: To estimate, upon competition heart rate (HR), exercise intensity during time trials (TT) in professional road cycling.
METHODS: Eighteen world-class cyclists completed an incremental laboratory cycling test to assess maximal power output (Wmax), maximal HR (HRmax), onset of blood lactate accumulation (OBLA), lactate threshold (LT), and a HR-power output relationship. An OBLA(ZONE) (HR(OBLA) +/- 3 beats x min(-1)) and a LT(ZONE) (HR(LT) +/- 3 beats x min(-1)) were described. HR was monitored during 12 prologue (<10 km, PTT), 18 short (<40 km, STT), 19 long (>40 km, LTT), eight uphill (UTT), and seven team (TTT) time trials. A HR-power output relationship was computed to estimate each cyclist's power output during TT racing from competition HR. Competition training impulse (TRIMP) values were estimated from HR and race duration.
RESULTS: %HRmax were 89+/-3%, 85+/-5%, 80+/-5%, 78+/-3%, and 82+/-2% in PTT, STT, LTT, UTT, and TTT, respectively. The amount of TRIMP were, respectively, 21+/-3, 77+/-23, 122+/-27, 129+/-14, and 146+/-6. Competition HR values relative to HR(OBLA) and HR(LT) were, respectively, 100+/-3%, 114+/-8% in PTT, 95+/-7%, 108+/-9% in STT, 89+/-5%, 103+/-8% in LTT, 87+/-2%, 101+/-5% in UTT, and 91+/-4%, 105+/-11% in TTT.
CONCLUSIONS: %HRmax, TRIMP and time distribution around HR(OBLA) and HR(LT) reflected the physiological demands of different TT categories. HR(OBLA) and HR(LT) were accurate intensity markers in events lasting, respectively, < or =30 (PTT and STT) and > or =30 min (LTT, UTT, TTT).

Entities:  

Mesh:

Year:  2000        PMID: 10776906     DOI: 10.1097/00005768-200004000-00019

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  29 in total

Review 1.  Specific aspects of contemporary triathlon: implications for physiological analysis and performance.

Authors:  David J Bentley; Grégoire P Millet; Verónica E Vleck; Lars R McNaughton
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Physiological and performance characteristics of male professional road cyclists.

Authors:  I Mujika; S Padilla
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  Adaptations to training in endurance cyclists: implications for performance.

Authors:  J A Hawley; N K Stepto
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 4.  Physiology of professional road cycling.

Authors:  A Lucia; J Hoyos; J L Chicharro
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Which laboratory variable is related with time trial performance time in the Tour de France?

Authors:  A Lucia; J Hoyos; M Pérez; A Santalla; C P Earnest; J L Chicharro
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

Review 6.  The physiology of mountain biking.

Authors:  Franco M Impellizzeri; Samuele M Marcora
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

7.  Exercise intensity and load during uphill cycling in professional 3-week races.

Authors:  Sabino Padilla; Iñigo Mujika; Juanma Santisteban; Franco M Impellizzeri; Juan José Goiriena
Journal:  Eur J Appl Physiol       Date:  2007-11-03       Impact factor: 3.078

Review 8.  Incremental exercise test design and analysis: implications for performance diagnostics in endurance athletes.

Authors:  David J Bentley; John Newell; David Bishop
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 9.  Distribution of power output during cycling: impact and mechanisms.

Authors:  Greg Atkinson; Oliver Peacock; Alan St Clair Gibson; Ross Tucker
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 10.  Describing and understanding pacing strategies during athletic competition.

Authors:  Chris R Abbiss; Paul B Laursen
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.